„Checkpoint“
Suchergebnisse
5.704 Treffer
-
The Greenlight Pathway – A Strategic Checkpoint System for Turning Raw Ideas Into Decisions That Get a Yes
-
The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer
-
Combination therapy of an 211At-labeled RGD peptide and immune checkpoint blockade to enhance antitumor efficacy
-
Targeting HIF-2α in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade
-
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993
-
Nuclear imaging of PD-L1 expression promotes the synergistic antitumor efficacy of targeted radionuclide therapy and immune checkpoint blockade
-
Assessment of the circulating levels of immune system checkpoint selected biomarkers in patients with lung cancer
-
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study
-
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer
-
The Arabidopsis 14-3-3 protein, GF14ω, binds to the Schizosaccharomyces pombe Cdc25 phosphatase and rescues checkpoint defects in the rad24 − mutant
-
Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis
-
Sublethal concentrations of high glucose prolong mitotic arrest in a spindle assembly checkpoint activity dependent manner in budding yeast
-
Computation algorithms for workload-dependent optimal checkpoint placement
-
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
-
Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review
-
Mucinous Colorectal Cancer is Associated With Expression of the TIM-3 Immune Checkpoint Independently of Microsatellite Instability (MSI) Status
-
Assessing immune organs on 18F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients
-
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
-
Physiologic colonic uptake of 18F-FDG on PET/CT is associated with clinical response and gut microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
-
Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors